Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on circulating endothelial progenitor cells in adults with prediabetes
ChiCTR-IPR-17012309Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in prediabetes (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: blood glucose and endothelial progenitor cell. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on ChiCTR-IPR-17012309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012309.